Have You Suffered Significant Losses Investing In Champignon Brands? Kehoe Law Firm, P.C. Class Action Investigation

Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C.

Class Action Lawsuit Filed On Behalf Of Investors Who Acquired The Securities Of Champignon Brands Between March 27, 2020 And February 17, 2021, Inclusive

PHILADELPHIA, PA, USA, April 12, 2021 /EINPresswire.com/ — Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of Champignon Brands Inc. (“Champignon” or the “Company”) (OTC: SHRMF) to determine whether the Company engaged in securities fraud or other unlawful business practices.

On April 10, 2021, a class action lawsuit was filed in United States District Court, Central District of California, on behalf of Champignon investors who purchased, or otherwise acquired, Champignon securities between March 27, 2020 and February 17, 2021, both dates inclusive (the “Class Period”).

According to the class action complaint, throughout the Class Period, the Champignon Defendants made false and/or misleading statements and/or failed to disclose that (1) Champignon had undisclosed material weaknesses and insufficient financial controls; (2) Champignon’s previously issued financial statements were false and unreliable; (3) Champignon’s earlier reported financial statements would need to be restated; (4) Champignon’s acquisitions involved an undisclosed related party; (5) as a result of the foregoing and subsequent reporting delays and issues, the British Columbia Securities Commission would suspend Champignon from trading; and (6) as a result, the Champignon Defendants’ statements about Champignon’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED SIGNIFICANT LOSSES ARE ENCOURAGED TO CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, KCAULEY@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

Kevin Cauley, Director, Business Development
Kehoe Law Firm, P.C.
+1 215-792-6676
info@kehoelawfirm.com


Source: EIN Presswire

Green Boom Introduces First USDA Certified Biodegradable Spill Kit

Innovative ‘green’ products clean the environment in convenient to-go package

Our spill kits include absorbents to confine the spill, ability to soak up fuels, oils, and lubricants and a USDA BioPreferred Certified bio based plastic bag for disposal.”

— Green Boom Co-Founder Sudhir Sharma

ATLANTA, GA, UNITED STATES, April 12, 2021 /EINPresswire.com/ — Green Boom is proud to introduce the first oil-only spill kit to earn the USDA BioPreferred Certification. Green Boom’s 100 percent biodegradable oil spill prevention, response and remediation products are ideal for storage in a new easy, to-go package for outdoor leaks or spills.

The Green Boom Spill Kit is available in three sizes, containing enough oil-only loose absorbent, pillows, socks, and mats to absorb five, ten, or forty gallons of fuel, oils and various oil-based liquids.

“The Green Boom team is proud to have developed the world’s first bio-based oil only spill kit,” said Green Boom Co-Founder Sudhir Sharma. “Our spill kits include absorbents to confine the spill, ability to soak up fuels, oils, and lubricants and a USDA BioPreferred Certified bio based plastic bag for disposal.”

Available in industry-standard sized pillows, socks, booms along with custom sizes, Green Boom’s products are made from patent-pending biomass up-cycling technologies that use sustainably sourced agricultural byproducts and textiles. Led by a team with broad chemical engineering experience, Green Boom created a technology that converts renewable, biodegradable and low-value agricultural materials into water-repellent, oil-only absorbents.

For more information about Green Boom and its bio-based, oil-only absorbent products, please visit www.GreenBoom.com.

# # #

Amy Parrish
Rhythm Communications
+1 404-310-6559
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Energy Solutions LP Is Exporting Crude Oil, LPG and Electricity Generation

Start of crude oil exports

Power generation exports

corporate logo

Energy Solutions LP is exporting crude oil, LPG and electricity generation

Energy Solutions LP is exporting crude oil, LPG and electricity generation”

— Clint Jackson

NEW YORK, NEW YORK, UNITED STATES, April 12, 2021 /EINPresswire.com/ — Energy Solutions LP made an announcement from their 14 Wall Street headquarters via their spokesman Clint Jackson with Greg Dupree, that they have been in final agreement talks with senior government officials in certain Asian nations including India and Pakistan. The points that enable the advancement of these sales include proprietary flexible, favorable financing terms such as "bootstrap sales" so the capital outlays are nominal for the institutional buyers that are importing this crude oil, liquefied petroleum gas (“LPG") and power generation energy products.

The opportunity is especially beneficial in rural areas, where they are to use LPG mini power-plants, essentially enlarged generators of 2 to 40 MWh in size, which shall be custom configured with a localized electricity distribution network among nearby area buildings. There will be joint venture production of these mini power-plants and reciprocal localized distribution grids built by selected US firms, pursuant to the long term power purchase agreements.

The favorable credit sales terms essentially create a new market of buyers that would otherwise not have the capital for such large volume purchases. A televised press conference is planned for May 31, 2021 10:00 AM local GMT as the agreements' signing ceremonies.

Greg Dupree
Energy-Solutions LP
+1 646-724-9331
Greg@Energy-SolutionLP.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Enuit for ETRM – CTRM – Continue to Expand Chinese Operations

Enuit award winner

Enuit award winner

Enuit has established itself in China and by virtue of having local employees and a Chinese setup, it has a bit of an edge on its international competitors.

BEIJING, CHINA, April 12, 2021 /EINPresswire.com/ — Earlier this month Mr Pengcheng Zheng, General Manager of Enuit China met with ComTech Advisory, the leading CTRM analyst firm to discuss the exceptional growth Enuit is having in China.

Mr Zheng said that he sees three areas of CTRM demand developing there. The first is in the traditional CTRM marketplace of the various medium and larger companies that procure, sell or trade commodities. The second are those companies that have a trade management system or ERP in place but need more advanced risk management and analytics. The third are those that are doing derivatives accounting management and want or need to add further risk controls and more analysis. This sounds pretty similar to the market for CTRM in other locations around the world showing that the market and appetite for CTRM software in China is following a familiar path, at least at a high level. Mr. Zheng also sees that Enuit’s Commodity Management strategy announced last year is positioning the company well for China.

Enuit now has a strong base in China with several offices, the latest of which opened recently in Shanghai. It has six Chinese clients and just won another large holding company that has subsidiaries in insurance, banking and financial services. It is deploying parts of Entrade such as strategy, commodity, contracts and deals to help this client to manage its supply chain finance business. Enuit has also hired five more people to form the team in Shanghai. “With a local and experienced team, we are building a strong Chinese brand,” Mr. Zheng told ComTech Advisory “The team will also be doing more than selling, supporting and implementing but also developing to meet local business requirements.” Enuit is also utilizing a network of local business partners particularly to sell and deliver to small businesses in the country.

One thing that is driving CTRM interest in China is the increasing complexity of commodity trading. As new exchanges and new instruments are launched like LPG, Fuel Oil, International Copper and others, more are using futures and options in order to try to boost flagging trading profits. More is yet to come with a new exchange set up in Southern China readying power and emissions instruments as well. The increasing complexity, particularly in managing risk along with a regulatory push to deploy international standard software, is helping drive demand, says Mr. Zheng.

ComTech Advisory notes that Enuit has established itself in China where it competes with local providers and IT shops and one or two other international vendors. However, by virtue of having local employees and a Chinese setup, it does appear to have a bit of an edge on its international competitors and is now deploying a two edge strategy that allows it to compete with local IT shops and providers as well.

Read the original blog post here:

https://www.ctrmcenter.com/blog/vendor-news-blog/enuit-continue-to-expand-chinese-operations/

Mark Tredway
Enuit LLC
+86 189 1020 3018
info@enuit.com
Visit us on social media:
Twitter
LinkedIn

What is CTRM? What is ETRM?


Source: EIN Presswire

KD Pharma Acquires Phytoextract and CBD Manufacturing Assets

KD Pharma Group plants and CBD extracts

KD Pharma Group

Phytoextract and CBD Manufacturing Assets

Phytoextract and CBD Manufacturing Assets

KD Pharma Group CBD and Phytoextracts

KD Pharma Group CBD and Phytoextracts

Transaction advances KD Pharma’s cannabinoid manufacturing strategy

We have committed to expanding our technology portfolio to develop APIs from cannabinoids and plant extracts”

— Oscar Groet

BIOGGIO, LUGANO, SWITZERLAND , April 12, 2021 /EINPresswire.com/ — The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The assets give KD Pharma access to technology for producing Active Pharmaceutical Ingredients (APIs) based on phytocannabinoids and other plant extracts. The technology further expands KD’s lipid technology portfolio and can be used in combination with KD’s other fractionation and separation technologies.

“KD Pharma is a leader in lipid technology focused primarily on omega-3s, but our technology suite has applications in other lipid sources like cannabinoids,” said Oscar Groet, CEO of the KD Pharma Group. “We have committed to expanding our technology portfolio to develop APIs from cannabinoids and plant extracts,” Groet continued, “and these assets give KD Pharma additional pathways to develop new products for this emerging market.”

The KD Pharma Group has also licensed a novel extraction method from Herbolea Biotech S.r.l. and expects to have a complete, licensed cGMP manufacturing facility online by the end of the year.

About the KD Pharma Group
The KD Pharma Group is a contract manufacturer that develops products in the pharmaceutical and nutraceutical space. It is also one of the largest Omega-3 fatty acid producers in the world with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents. Visit www.kdpharmagroup.com to learn more.

Adam Ismail, Chief Strategy Officer
KD Pharma Group
+1 385-237-2787
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Methanol Institute Formalizes Collaboration with Indonesia’s Ministry of Energy and Mineral Resources

MI and Indonesia’s Ministry of Energy and Mineral Resources collaborate on developing production and consumption of methanol as an energy product in Indonesia.

I believe that we have a lot to learn from each other, and this partnership will facilitate our shared growth.”

— Gregory Dolan, CEO, Methanol Institute

WASHINGTON, DC, UNITED STATES, April 12, 2021 /EINPresswire.com/ — The Methanol Institute (MI) and Indonesia’s Ministry of Energy and Mineral Resources (MEMR) held a signing ceremony of a Letter of Interest (LOI) on March 30, 2021. The LOI was signed to formalize their partnership on developing methanol as an energy product in Indonesia.

The signing ceremony was a culmination of dialogue between MEMR representatives and MI staff on how methanol could play a strategic role in the continued development of Indonesia’s economy. Under the LOI, the MI will support the MEMR with organizing knowledge sharing workshops with government representatives and private sector individuals. These knowledge sharing sessions are aimed to provide a platform for the exchange of information about developing both the production and consumption of methanol as an energy product in Indonesia. MI will also leverage its global experience in working with different governments to develop their methanol industries to provide MEMR and their sister ministries with policy recommendations. Policy recommendations will be targeted at fostering a constructive ecosystem with the necessary governmental support to develop a local methanol industry.

The LOI signing ceremony commenced with opening remarks from Professor Tutuka Ariadji, Director General Oil and Gas, MEMR, who stated, “I would like to thank the Methanol Institute for their support for the development of the methanol industry in Indonesia. I hope that through the support of the Methanol Institute, the utilization of methanol as an energy resource can accelerate Indonesia’s use of clean energy and support the country’s energy security.”

Professor Ariadji’s sentiments was welcomed MI’s CEO Gregory Dolan, “I believe that we have a lot to learn from each other, and this partnership will facilitate our shared growth. More importantly, I believe this partnership will serve as a strong platform for the creation of economic opportunities in Indonesia as it continues its journey of economic success.”

###

About MI

The Methanol Institute (MI) serves as the global trade association for the methanol industry, representing the world’s leading producers, distributors, and technology companies. Founded in 1989 in Washington DC, MI now represents its members from five offices around world in Washington DC, Beijing, Brussels, Delhi, and Singapore.

Tim Chan
Methanol Institute
+65 9776 3530
email us here


Source: EIN Presswire

BARITAINER®: Tight Head Containers Manufactured by Mauser Packaging Solutions

Barrier Plastics

Baritainer

Mauser Packaging Solutions

Baritainers® are mono-layer Kortrax® and High-Density Polyethylene UN Rated Tight Heads manufactured by Mauser Packaging Solutions.

CHARLOTTESVILLE, VA, UNITED STATES, April 12, 2021 /EINPresswire.com/ — Baritainers® are mono-layer Kortrax® and High-Density Polyethylene UN Rated Tight Heads manufactured by Mauser Packaging Solutions. Baritainers® are a barrier container intended as a safe replacement for either fluorinated packaging or steel drums and tight heads.

Mauser Packaging Solutions has been selected by Barrier Plastics as the manufacturing partner to produce Baritainers®. Baritainers® are of a monolayer construction made with Kortrax® Barrier Resin and HDPE. The intended purpose of Baritainers® is the safe transportation of solvent based products such as agricultural chemicals, industrial chemicals, automotive additives, cleaning solvents and food products such as flavors, fragrances, and essential oils.

Baritainers® are a safe and environmentally friendly alternative to fluorinated plastic containers. Fluorine or fluorine compounds are not utilized when Kortrax® Barrier Resin is included within HDPE containers, and recent analysis has not identified any PFAS, PFOS compounds in containers or filling goods stored in Kortrax®/HDPE constructed packages aka Baritainers®. Kortrax® imparts the chemical resistance associated with a fluoropolymer treatment of HDPE containers and adds the benefit of oxygen, carbon dioxide
and water vapor permeation inhibition as well.

Baritainers® are FDA and EU compliant. And, unlike multi-layer EVOH containers which are recycle code 7, Baritainers® are classified as recycle code 2. (https://baritainer.com/technology/) And, with the increased cost and tight availability of lined steel tight heads, Baritainers® are an economical and readily available alternative. Thus, Baritainers® are not only human safe but also more sustainable than other alternative barrier container technologies.

“We are thrilled to be working with the Small Packaging Group of Mauser Packaging Solutions in supporting and expanding the Baritainer® tight head product line,” stated Kevin Callahan, COO of Barrier Plastics. “Currently we offer 4L, 5L, 10L, and 20L Baritainers®,” he added, “but, we are expanding to include 12L, 15L and other sizes and configurations that Mauser Packaging Solutions produces.”

“Mauser Packaging Solutions strives to provide customers, and the market, with innovative packaging solutions that reduce our mutual impact on the environment,” commented Mark Puchalla, Director Plastic Business Development Small Packaging Mauser Packaging Solutions. “This product was a fantastic addition to our portfolio to address our customers’ growing demand for barrier packaging that meets increasing sustainability and human safety requirements,” he added.

Kevin Callahan
Barrier Plastics
+1 9496063550
kevin@barrierplastics.com


Source: EIN Presswire

TOXIC EXPOSURE MILITARY VETERANS REVEAL THE PATIENT-ABUSE NIGHTMARE OF FILING DISABILITY CLAIMS AT THE VA AGENCY

Engineers report cover that holds half of the ten exposure pathway reports used by the McClellan Vets as proof of their toxic exposures.

An EPA report cover that holds the exposure pathway report for the Monsanto Factory spill covering McClellan Vets as “commercial visitors” in the declared exposure populations.

Veterans who are inside the system liken the VA & Capitol Hill Committees to enablers of a modern-day Bataan Death March.

ALBANY, NEW YORK, USA, April 12, 2021 /EINPresswire.com/ — The Dept. of Veterans Affairs agency is running a corrupt and incompetent disability claims process for environmental toxic exposure veterans who passed through verified contamination sites while they were on military active duty. This is part of the revelations that insider veterans are making to get the word out to the public about what’s really going on from inside the system. The program is more commonly known as the VA Compensation and Pension benefit. It’s run exclusively by non-medical administrators at the Veterans Benefits Administration and is not under the department oversight of the Veterans Health Administration where the doctors are.

The national medical patient group known as Toxic Exposure Army Veterans of Fort McClellan, have been on the receiving end of the VA’s corrupted practices since the year 2003. They are still in processing limbo and are unresolved inside the program.
The group argues the entire process that VA is using for veterans to identify themselves with as hazardous exposures cases, is primarily rooted in two separate illegal practices. One malpractice they have identified is the use of patient abuse tactics from inside the claims process by rogue and harassing raters. Current VA regulatory laws only prohibits the schemes of patient abuse while veterans are inpatients at the VA Hospitals. For them, it’s open season for crimes from these rogue raters.

The second malpractice is for the raters and exam doctors to use the claims process to impose practices of discrimination on the basis of the disabilities and handicaps of the filing veterans. They say the VA violates its own protection laws which are set up to oppose the use of discrimination practices to block them from accessing federal programs. This can include illegal patient lockouts from their military benefits and an organized refusal by the VA to even process the application forms filed by toxic exposure patient groups. The veterans say there is no specific law that empowers the VA to refuse to process their cases correctly, or to deny their benefits wholesale based on the simple fact they are medically-matched to the known toxic sources at their military service site.

Toxic exposures in the veteran’s arena, are the outcome of an engineering declaration made in site reports at the time an environmental contamination zone is discovered. Environmental engineers are a licensed workforce that answers exclusively to the data measurement standards which are set forth by the Environmental Protection Agency on any given day. The veterans argue that the VA has no legal standing to argue with or to refuse to apply the environmental declarations that are made by military or civilian engineers to their VA disability cases.

Toxic exposure evidencing for certain population groups, are found in the engineering declarations as three different formats. The veterans argue there is no one at the VA who is competent enough to read the engineering papers to locate the three primary pages of evidence that they have to use to establish their disability claims with. It’s an odd processing obstacle for them to first have to find and submit the evidence pages on their own as disadvantaged medical patients, and then to have to submit the pages to a rater workforce who is academically inadequate to even apply them to the veteran’s cases.

The three basic papers of evidence that verifies and proves certain military veterans were exposed to toxic sources at a contamination zone are known. But the veterans argue that readers do have to be skilled enough in locating the papers, which are often embedded within hundreds of other pages holding dismissable topics. One format is called a Hazard Rating Scale or (HRS). A Hazard Rating Scale is a math scoring formula which is calculated against the numerical threshold limits that are established by either the EPA Superfund or National Priorities List (NPL) programs. The second format for evidencing is called an exposure pathway report. The toxic spill site names out the pathways of air, water, or soil as the routes of toxic exposures, and then names out the estimated exposure population groups that are most likely to show health risk developments. The third format for evidencing is the remedial cleanup actions that are ordered by state or federal environmental agencies. Any one of these formats, or combinations of them from the three choices, are the body of evidence used by the industry to establish toxic exposures to medical patients.

The McClellan Vets group is holding all three collections of engineering papers to evidence their group case with before the VA. They say it’s the VA who has been using wrong engineering papers that are deliberately selected to support a false narrative to suggest that nothing toxic was found at the Army base or that soldiers were not exposed to anything toxic.

The veterans also say that the VA disability claims process is overrun with conflicted filing forms, rater incompetence, rater hate-crimes and discriminatory practices, exam doctor falsifications of DBQ papers, and meddling civilians who dominate the legislative committees where the veterans have to go for remedy bills for each groups personal VA crisis. They point to the new false narrative coming out from the Twitter accounts of committees right now that suggests the veterans have to either be deployed or in combat service in order to be recognized at the VA for toxic exposure claims. This is widely known to be a lie in the veteran’s arena where the statutory Basic Entitlement laws covers both war era and peacetime era veterans for their health claims.

The McClellan Vets feel that the only real solution to the layers of corruption at the VA claims process is for the Dept. of Justice, the FBI, and the U.S. Attorney’s Office to form a Task Force to collect statements from the veterans for the review of possible interagency prosecutions.

Sue Frasier, Activist
Toxic Exposure Army Veterans of Fort McClellan
ft_mcclellan_vets1@yahoo.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Drug Repurposing Screens Reveal Nine Potential New COVID-19 Treatments

VulcanChem – Global Leading Supplier of Research Chemicals

VulcanChem – Global Leading Supplier of Research Chemicals

PASADENA, CALIFORNIA, UNITED STATES, April 11, 2021 /EINPresswire.com/ — Coronaviruses represent a large group of medically relevant viruses that were historically associated with the common cold. However, in recent years, members of the coronavirus family have emerged from animal reservoirs into humans and have caused novel diseases. Although SARS was in the end eradicated, MERS continues to cause infections in the Middle East. Beginning in December 2019, SARS-CoV-2 created a worldwide pandemic.

Identification of broadly acting SARS-CoV-2 antivirals is essential to clinically address SARS-CoV-2 infections. A potential route to candidate antivirals is through the deployment of drugs that show activity against related viruses. Previous studies found that the antiviral drug remdesivir, which was developed against the RNA-dependent RNA polymerase of Ebola virus, was also active against SARS-CoV-2 in vitro, with promising results in clinical trials. Recently a team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases.

The research team developed a specific and sensitive assay to quantify viral infection using a cell-based high-content approach. They screened thousands of existing drugs and drug-like molecules for their ability to inhibit the replication of SARS-CoV-2. The screens tested the molecules for anti-coronaviral activity in a variety of cell types, including human airway-lining cells that are similar to the ones principally affected in COVID-19.

Of the nine drugs found to reduce SARS-CoV-2 replication in respiratory cells, three already have FDA approval: the transplant-rejection drug cyclosporine, the cancer drug dacomitinib, and the antibiotic salinomycin. These could be rapidly tested in human volunteers and COVID-19 patients. The experiments also shed light on key processes the coronavirus uses to infect different cells and found that the antiviral drug remdesivir, which has an FDA Emergency Use Authorization for treating COVID-19, does appear to work against the virus in cell-culture tests on respiratory cells, whereas hydroxychloroquine does not.

The study highlights cyclosporine as particularly promising, as it appears to works against SARS-CoV-2 in respiratory and non-respiratory cells, and via two distinct mechanisms: inhibiting cell enzymes called cyclophilins, which the coronavirus hijacks to support itself, and suppressing the potentially lethal inflammation of severe COVID-19.

Valerie Walters
VulcanChem
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

Provivi® announces regulatory approval in Indonesia

Scirpophaga incertulas, yellow rice stem borer

The registration of Pherium AL offers a preventive, proven, and safe technology to rice growers in Indonesia

Farmers in Indonesia now have a tool to rethink the way to protect crops, as we offer an effective and safe foundation for Integrated Pest Management (IPM) of stemborer in rice”

— Dr. Pedro Coelho, Co-Founder, and CEO of Provivi

SANTA MONICA, CALIFORNIA, UNITED STATES, April 12, 2021 /EINPresswire.com/ — Provivi® Inc ("Provivi"), an emerging crop protection company using pheromones to protect crops from major damaging insects, proudly announces regulatory approval of "Pherium AL" in Indonesia. The authorization issued by the Indonesian Ministry of Agriculture covers the control of yellow rice stemborer (Scirpophaga incertulas) in rice.

Rice stemborers are an important damaging pest for Indonesian rice growers. Current tools to control the pest are often costly and lagging efficacy, while at times posing health risks to the applicators and farmers.

Pherium AL is a pheromone-based product, which will change the way farmers in Indonesia manage the stemborer problem. One application at the beginning of the crop will provide season-long control by disrupting the mating cycle of the pest and prevent the build-up of damaging populations.

“For Provivi, farmers are the cornerstone of our organization, and we are grateful and excited to be able to offer to farmers a preventive, sustainable, and non-toxic solution against stemborer – improving their rice crops, business, and livelihoods”, stated Mr. Pedro Coelho, CEO, and Co-Founder of Provivi.

“By adopting the Pherium AL solution, farmers in Indonesia now have a tool enabling them to rethink the way to protect their rice crop from damaging insect pest populations. Being a natural compound with no risk of resistance, it offers an effective and safe foundation for Integrated Pest Management (IPM) of stemborer in rice.”, Mr. Coelho added.

“This registration marks the beginning of a new era of effective, affordable, and environmentally benign protection against stemborer for farmers not only in Indonesia but several other countries across Asia, where we are currently developing and registering the product.” Said Mr. Juan Manuel Lombana, VP Global Business at Provivi.

About Pheromones & Mating Disruption
Pheromones are natural signal substances, produced by insects. They serve several purposes. One such is to promote reproduction when females emit specific sex pheromones to attract males for their mating.
This has been commercially used by introducing dispensers or spray applications saturating the field with those pheromones. The high concentration of pheromones confuses male insects, and they fly around unable to locate the females. The mating is prevented, and pest infestation's growth is controlled in a preventive way without killing any insects.
This technology has been used for the past thirty years and is currently applied in more than one million hectares of high-value permanent crops such as apples, grapes, and nuts. The benefits of using pheromones are well established in the scientific literature: they enable a reduction of harmful residues on food while preserving biodiversity.

About Provivi’s pheromones
The traditionally high cost of synthesizing pheromones has been a barrier to the adoption of this technology in low-cost, large hectarage row crops. Provivi uses proprietary production methods and low-cost raw materials to ensure high volumes and reduced costs. As a result, Provivi’s affordable pheromone products can be adopted in a crop like rice, where PheriumTM AL has demonstrated effective control of stemborers.

About Provivi
We are a groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world.
Provivi is developing a family of safe, effective, and economical pheromone solutions, creating a new foundation for pest and resistance management in crop production. Pheromones are substances that serve as highly selective attractants for insects, allowing the control of harmful pests while preserving beneficial insects. Provivi's patented production method enables a step-change in the cost of manufacturing pheromones, allowing the use of this proven tool in high-acreage crops such as corn, rice, and soy.

For more information, visit www.provivi.com

Media Contacts
JP Vollmers-Hansen, Director Global Marketing jpvollmers-hansen@provivi.com

Jens Peter Vollmers-Hansen
Provivi Inc.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Welcome to Provivi


Source: EIN Presswire